Assembly Biosciences Inc (NASDAQ:ASMB)

7.26
Data as of Aug 29
 -0.04 / -0.55%
Today’s Change
4.25
Today|||52-Week Range
23.45
-61.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$63.1M

Company Description

Assembly Biosciences, Inc. operates as a biopharmaceutical company which develops novel treatments for hepatitis B virus infection and C. difficile-associated diarrhea. It specializes in the development of therapies for infectious diseases like HIV, CDAD and other disorders of the gastrointestinal system including of late-stage and pre-clinical prescription drugs and biologics. The company was founded on October 7, 2005 and is headquartered in New York, NY.

Contact Information

Assembly Biosciences, Inc.
99 Hudson Street
New York New York 10013
P:(646) 706-5208
Investor Relations:

Employees

Shareholders

Other institutional27.23%
Mutual fund holders2.24%
Individual stakeholders--

Top Executives

Russell H. EllisonChairman, CEO & Co-Chief Medical Officer
Derek A. SmallPresident, COO, Director & Budget Chief
David J. BarrettChief Financial Officer
Lee D. ArnoldChief Scientific Officer
Uri A. LopatinCo-Chief Medical Officer, Vice President-R&D

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.